Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Molecular and Cellular Biology

Abstract 2276: Coordinate autophagy and PI3K/Akt/mTOR pathway inhibition enhances cell death in melanoma

Xiaoqi Xie, Janice M. Mehnert and Eileen P. White
Xiaoqi Xie
1The Cancer Institute of New Jersey/UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janice M. Mehnert
1The Cancer Institute of New Jersey/UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eileen P. White
2The Cancer Institute of New Jersey; Rutgers University, New Brunswick, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2012-2276 Published April 2012
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL

Abstract

The PI3K/Akt/mTOR pathway is a critical survival pathway in numerous malignancies, including melanoma. Inhibitors of this pathway in cancer cells, in particular mTOR, are commonly cytostatic rather that cytotoxic, which may potentially limit efficacy of these agents. mTOR inhibition also induces the survival pathway of autophagy, a catabolic process whereby cells collect and recycle cellular components to sustain energy homeostasis. Thus we tested the hypothesis that autophagy induction by mTOR inhibitors directly limited their efficacy for the treatment of melanoma. Here we found that melanoma exhibits high basal levels of autophagy, as evidenced by a) detection of autophagosomes using LC3 fluorescence and autophagic flux in multiple melanoma cell lines and b) increased LC3 fluorescence in human primary and metastatic melanomas compared to benign nevi. Knockdown of Atg7, a key element of autophagy machinery, resulted in cell death, indicating that survival of melanoma cells is autophagy dependent. We also showed that the autophagy inhibitor hydroxychloroquine (HCQ) shows synergy when combined with the mTOR inhibitor CCI-779 (temsirolimus), inducing cell death via increased apoptosis in melanoma cell lines and in 3-D spheroid cell cultures. Since autophagy eliminates mitochondria that are a source of toxic reactive oxygen species (ROS) and mediators of apoptosis, we tested the possibility that this contributed to melanoma survival. To test this potential mechanism, we examined the role of the transcription factor Nrf2, a master regulator of antioxidant defense. Treatment with CCI-779 inactivated Nrf2 by blocking its nuclear translocation and creating the requirement for autophagy to eliminate ROS-producing mitochondria. Combination treatment with CCI-779 and HCQ then prevented mitochondrial elimination by autophagy, resulting in increased ROS production compared to either agent alone and increased cell death. Conversely, knockdown of the Nrf2 binding protein and inhibitor Keap1 increased Nrf2 activity, resulting in increased cell culture survival and resistance to treatment with CCI-779 and HCQ. These data suggest that coordinate inhibition of the PI3K/Akt/mTOR and autophagy pathways promotes ROS-mediated apoptosis and is a new therapeutic paradigm for the treatment of melanoma.

Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2276. doi:1538-7445.AM2012-2276

  • ©2012 American Association for Cancer Research
Back to top
Cancer Research: 72 (8 Supplement)
April 2012
Volume 72, Issue 8 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 2276: Coordinate autophagy and PI3K/Akt/mTOR pathway inhibition enhances cell death in melanoma
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 2276: Coordinate autophagy and PI3K/Akt/mTOR pathway inhibition enhances cell death in melanoma
Xiaoqi Xie, Janice M. Mehnert and Eileen P. White
Cancer Res April 15 2012 (72) (8 Supplement) 2276; DOI: 10.1158/1538-7445.AM2012-2276

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 2276: Coordinate autophagy and PI3K/Akt/mTOR pathway inhibition enhances cell death in melanoma
Xiaoqi Xie, Janice M. Mehnert and Eileen P. White
Cancer Res April 15 2012 (72) (8 Supplement) 2276; DOI: 10.1158/1538-7445.AM2012-2276
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Molecular and Cellular Biology

  • Abstract RAOS15-03: Pancreatic tumor stroma as a therapeutic target
  • Abstract DDT02-01: Inhibition of the AAA-ATPase p97 with the first in class inhibitor CB-5083 as a novel approach to treat cancer
  • Abstract LB-298: The multiple-myeloma associated snoRNA, ACA11 increases oxidative stress and cell proliferation
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Regulation of Cell Death

  • Abstract 2269: Lapatinib and obatoclax kill cns tumor cells through blockade of erbb1 / 3 / 4 and through inhibition of bcl-xl and mcl-1
  • Abstract 2259: Oncolytic attenuated measles virus exploits autophagy for its replication and spreads by suppressing Rig-1 like receptors (RLRs) in non-small cell lung cancer cells
  • Abstract 2264: Autophagy inhibition sensitizes the growth inhibitory effects of propolin C but not propolin G on human lung adenocarcinoma A549 cells
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement